Skip to main content
. 2020 Oct 6;4(5):565–574. doi: 10.1016/j.mayocpiqo.2020.05.005

Table 1.

Baseline Demographic and Clinical Features of Study Patientsa,b

Parameter Total (N=271) TBFB (n=151) TBCB (n=120) P valuec
Age (y) 61±14 59±14 62±14 .091
Male sex 143 (53) 76 (50) 67 (56) .37
Smoking history 91 (34) 48 (32) 43 (36) .51
COPD 16 (6) 11 (7) 5 (4) .27
Pulmonary hypertensiond 21 (8) 17 (12) 4 (3) .011
Obstructive sleep apnea 37 (14) 24 (16) 13 (11) .20
CTD 46 (17) 25 (17) 21 (18) .90
Renal insufficiency 5 (2) 4 (3) 1 (1) .26
Body mass index (kg/m2) 30±7 30±8 30±6 .99
Resting Spo2% 92.5±11 94±4 91±15 .22
Supplemental oxygen 13 (5) 7 (6) 6 (5) .93
FEV1% predicted 74±20 74±20 73±21 .84
FEV1/FVC 77±12 77±11 76±12 .81
FVC% predicted 77±18 78±19 75±18 .27
TLC% predicted 82±17 84±17 79±17 .065
DLCO% predicted (corrected for Hgb) 64±19 65±19 51±27 .20
a

COPD = chronic obstructive pulmonary disease; CTD = connective tissue disease; DLCO = single-breath diffusing capacity for carbon monoxide; FEV1 = forced expiratory volume in 1 second; FVC = forced vital capacity; Hgb = hemoglobin (g/dL); Spo2 = peripheral capillary oxygen saturation; TBCB = transbronchial cryobiopsy; TBFB = transbronchial forceps biopsy; TLC = total lung capacity.

b

Data are presented as mean ± SD for continuous variables or as No. (percentage) for categorical variables.

c

Kruskal-Wallis for continuous variables and χ2 test for categorical variables.

d

Echocardiographic results not available for 62 patients who underwent TBFB (44.9%) and 55 patients who underwent TBCB (47.4%).